miR-381 overcomes cisplatin resistance in breast cancer by targeting MDR1
Author:
Affiliation:
1. Department of General Surgery; Nanjing Drum Tower Hospital; Nanjing Jiangsu Province 210008 China
2. Department of General Surgery; Drum Tower Clinical Medical College of Nanjing Medical University; Nanjing Jiangsu Province 210008 China
Funder
Nanjing Medical Science and Technology Development Project
Publisher
Wiley
Subject
Cell Biology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/cbin.11071/fullpdf
Reference36 articles.
1. Regulation of multidrug resistance by microRNAs in anti-cancer therapy;An;Acta Pharm Sin B,2017
2. MicroRNAs: target recognition and regulatory functions;Bartel;Cell,2009
3. A brief review on the mechanisms of miRNA regulation;Cai;Genomics Proteomics Bioinformatics,2009
4. MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression;Cao;J Exp Clin Cancer Res,2017
5. MiR-381, a novel intrinsic WEE1 inhibitor, sensitizes renal cancer cells to 5-FU by up-regulation of Cdc2 activities in 786-O;Chen;J Chemother,2013
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The regulation of microRNAs on chemoresistance in triple-negative breast cancer: a recent update;Epigenomics;2024-04-19
2. Oncogenic miR-106b-5p promotes cisplatin resistance in triple-negative breast cancer by targeting GDF11;HISTOL HISTOPATHOL;2024
3. Histone acetylation: a key determinant of acquired cisplatin resistance in cancer;Clinical Epigenetics;2024-01-03
4. LncRNA CTBP1-AS2 Influences Cellular Activities via miR-381-3p/ID1 Axis in Breast Cancer;Russian Journal of Genetics;2023-12
5. TMEM16A ion channel: A novel target for cancer treatment;Life Sciences;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3